• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?

作者信息

Thomas Mike, Pavord Ian

出版信息

Prim Care Respir J. 2012 Mar;21(1):8-10. doi: 10.4104/pcrj.2012.00022.

DOI:10.4104/pcrj.2012.00022
PMID:22367253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6547900/
Abstract
摘要

相似文献

1
Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?基层医疗中哮喘管理的单吸入器维持和缓解治疗（SMART）：我们目前处于什么阶段？
Prim Care Respir J. 2012 Mar;21(1):8-10. doi: 10.4104/pcrj.2012.00022.
2
Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.布地奈德/福莫特罗：作为哮喘维持和缓解吸入疗法的应用综述
Drugs. 2007;67(16):2407-31. doi: 10.2165/00003495-200767160-00007.
3
Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control.布地奈德/福莫特罗维持与缓解治疗在基层医疗哮喘管理中的应用：对支气管高反应性和哮喘控制的影响
Prim Care Respir J. 2012 Mar;21(1):50-6. doi: 10.4104/pcrj.2011.00090.
4
A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.布地奈德/福莫特罗维持和缓解治疗与西班牙哮喘管理常规最佳实践的比较。
J Asthma. 2011 Oct;48(8):839-47. doi: 10.3109/02770903.2011.611954.
5
Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States.开始解决哮喘治疗中的实施差距问题：美国临床医生对处方缓解药物布地奈德-福莫特罗吸入剂和 SMART 的看法。
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2767-2777. doi: 10.1016/j.jaip.2023.05.023. Epub 2023 May 26.
6
[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].[布地奈德/福莫特罗维持与缓解治疗。一种针对成年哮喘患者的新治疗方法]
Med Klin (Munich). 2008 May 15;103(5):299-310. doi: 10.1007/s00063-008-1050-y.
7
Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials.布地奈德/福莫特罗用于哮喘的维持和缓解治疗：一项随机对照试验的荟萃分析。
Int J Clin Pract. 2010 Apr;64(5):619-27. doi: 10.1111/j.1742-1241.2009.02320.x.
8
Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma.布地奈德/福莫特罗或布地奈德/沙丁胺醇作为哮喘的抗炎缓解治疗。
J Allergy Clin Immunol Pract. 2024 Apr;12(4):889-893. doi: 10.1016/j.jaip.2024.02.003. Epub 2024 Feb 10.
9
Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.布地奈德/福莫特罗维持和缓解治疗在亚洲哮喘患者（≥16 岁）中的应用：COSMOS 研究的一项亚分析。
Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.
10
Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.迈向推荐分级评估、制定与评价系统：布地奈德/福莫特罗维持缓解治疗研究的方法与结果。
Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):361-74. doi: 10.1097/ACI.0b013e3283489c0e.

引用本文的文献

1
Quantitative CT Metrics for the Prediction of Therapeutic Effect in Asthma.定量CT指标预测哮喘治疗效果
J Clin Med. 2023 Jan 13;12(2):639. doi: 10.3390/jcm12020639.
2
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.布地奈德/福莫特罗准纳器在英国用于哮喘和慢性阻塞性肺疾病管理的真实世界有效性评估
BMJ Open. 2018 Oct 27;8(10):e022051. doi: 10.1136/bmjopen-2018-022051.
3
Recent changes in the drug treatment of allergic asthma.过敏性哮喘的药物治疗近期变化。
Clin Med (Lond). 2013 Oct;13(5):477-81. doi: 10.7861/clinmedicine.13-5-477.

本文引用的文献

1
Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control.布地奈德/福莫特罗维持与缓解治疗在基层医疗哮喘管理中的应用：对支气管高反应性和哮喘控制的影响
Prim Care Respir J. 2012 Mar;21(1):50-6. doi: 10.4104/pcrj.2011.00090.
2
Update on asthma control in five European countries: results of a 2008 survey.五个欧洲国家的哮喘控制现状更新：2008 年调查结果。
Eur Respir Rev. 2010 Jun;19(116):150-7. doi: 10.1183/09059180.00002110.
3
Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma.福莫特罗与短效β受体激动剂作为成人和儿童哮喘缓解药物的比较。
Cochrane Database Syst Rev. 2010 Sep 8;2010(9):CD008418. doi: 10.1002/14651858.CD008418.pub2.
4
Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal.哮喘的单一维持和缓解治疗（SMART）：批判性评价。
Thorax. 2010 Aug;65(8):747-52. doi: 10.1136/thx.2009.128504. Epub 2010 Jun 27.
5
Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children.福莫特罗与布地奈德联合作为维持和缓解治疗与吸入性糖皮质激素维持治疗对成人和儿童慢性哮喘的疗效比较
Cochrane Database Syst Rev. 2009 Apr 15(2):CD007313. doi: 10.1002/14651858.CD007313.pub2.
6
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.高剂量固定剂量或低剂量固定剂量加按需使用布地奈德/福莫特罗治疗的哮喘患者的气道炎症
J Allergy Clin Immunol. 2009 May;123(5):1083-9, 1089.e1-7. doi: 10.1016/j.jaci.2009.02.034. Epub 2009 Apr 14.
7
Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children.福莫特罗与吸入性类固醇联合用药与β2受体激动剂作为成人和儿童慢性哮喘缓解药物的比较
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD007085. doi: 10.1002/14651858.CD007085.pub2.
8
Achieving asthma control in practice: understanding the reasons for poor control.在实际中实现哮喘控制：理解控制不佳的原因。
Respir Med. 2008 Dec;102(12):1681-93. doi: 10.1016/j.rmed.2008.08.003. Epub 2008 Sep 23.
9
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?哮喘患者吸入糖皮质激素的依从性差：使用含有布地奈德和福莫特罗的单一吸入器是否有帮助？
Br J Gen Pract. 2008 Jan;58(546):37-43. doi: 10.3399/bjgp08X263802.
10
Scientific rationale for using a single inhaler for asthma control.使用单一吸入器控制哮喘的科学依据。
Eur Respir J. 2007 Mar;29(3):587-95. doi: 10.1183/09031936.00080306.